TPO and Thrombocytopenia: To treat thrombocytopenia, recombinant TPO (rTPO) was used initially to enhance the production of platelets in patients, but its use was discontinued later due to the production of neutralizing anti-TPO antibodies, which cross-react with endogenous TPOs and result in a return of thrombocytopenia [27].